BioWorld MedTech

Nov. 20, 2012

Medica 2012: iHealth Lab opens new channels for device sales

DÜSSELDORF — What sounds like a concept that fits seamlessly with the exploding use of iPhones, iPads is actually a company that stole the show at the world's largest exhibition for medical devices. Read More

Exact Sciences completes: enrollment for Deep-C trial

Phase III Starts Early Next Year: Intarcia pumps up with $210M for once-yearly exenatide bid

Deals roundup: Wright to pay up to $380M in cash/stock for BioMimetic

Patent watch: Cadium wins decision for heart disease gene therapy

Report from Europe: St. Jude snags European approval of Portico valve

Agreements/contracts: DR Systems, Mach7 form alliance for imaging tech

HIT roundup: NextGen launches new 8 Series EHR Content

Product Briefs

People in the News

Med-Tech Notes

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.